Stay updated with breaking news from Enteric Hyperoxaluria. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synlogic, Inc. (NASDAQ:SYBX – Get Rating) insider Aoife Brennan sold 8,894 shares of the stock in a transaction dated Monday, April 4th. The stock was sold at an average price of $2.45, for a total transaction of $21,790.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at […]
Synlogic, Inc. (NASDAQ:SYBX – Get Rating) has earned a consensus recommendation of “Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued a […]
Synlogic (NASDAQ:SYBX – Get Rating)‘s stock had its “buy” rating reaffirmed by equities researchers at Oppenheimer in a research report issued on Friday, TipRanks reports. They presently have a $7.00 target price on the biotechnology company’s stock. Oppenheimer’s target price suggests a potential upside of 213.90% from the stock’s current price. A number of other […]
Synlogic (NASDAQ:SYBX – Get Rating) had its price objective cut by stock analysts at SVB Leerink from $11.00 to $8.00 in a report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. SVB Leerink’s target price points to a potential upside of 292.16% from the company’s previous […]
Zacks Investment Research cut shares of Synlogic (NASDAQ:SYBX – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, “Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and […]